SURAKSHA — Suraksha Diagnostic Share Price
Last trade - 00:00- IN₹16.04bn
- IN₹16.33bn
- IN₹2.19bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.26 | ||
| Price to Tang. Book | 8.33 | ||
| Price to Free Cashflow | 103.27 | ||
| Price to Sales | 7.46 | ||
| EV to EBITDA | 23.22 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.16% | ||
| Return on Equity | 13.37% | ||
| Operating Margin | 17.76% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 2,231.93 | 1,901.34 | 2,187.09 | n/a | n/a | -1.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -60.22 | +196.21 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Suraksha Diagnostic Limited is an India-based company. The Company is primarily engaged in the business of running diagnostic centers for carrying out various pathological and radiological services. The Company offers integrated solutions for pathology and radiology testing, and medical consultation services to its customers through its operational network. Its services include Imaging, Neurology, Cardiology, Gastroenterology, and Pathology. Its Imaging services include X-Ray, DEXA scan, USG scan, CT scan and others. Its Neurology services include EEG, EMG, NCV. Its Cardiology services include Echocardiogram Test, Stress Test / Treadmill Test, Holter Monitoring, Color Doppler, Peripheral Doppler, and others. Its Pathology services include Microbiology, Cytogenetic, Serology, Molecular Biology, Histopathology, Cytopathology, Haematology, and others. Its Gastroenterology services include Upper GI Endoscopy, Sigmoidoscopy, Colonoscopy, Proctoscopy, Proctosigmoidoscopy, and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 15th, 2005
- Public Since
- December 6th, 2024
- No. of Employees
- 1,173
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 52,080,758
- Address
- KOLKATA, 700156
- Web
- https://www.surakshanet.com/
- Phone
- +91 3366059750
- Auditors
- MSKA & Associates
Similar to SURAKSHA
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
As of Today at 23:30 UTC, shares in Suraksha Diagnostic are trading at IN₹313.10. This share price information is delayed by 15 minutes.
Shares in Suraksha Diagnostic last closed at IN₹313.10 and the price had moved by over the past 365 days. In terms of relative price strength the Suraksha Diagnostic share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreSuraksha Diagnostic does not currently pay a dividend.
Suraksha Diagnostic does not currently pay a dividend.
Suraksha Diagnostic does not currently pay a dividend.
To buy shares in Suraksha Diagnostic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹313.10, shares in Suraksha Diagnostic had a market capitalisation of IN₹16.04bn.
Here are the trading details for Suraksha Diagnostic:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SURAKSHA
Based on an overall assessment of its quality, value and momentum Suraksha Diagnostic is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Suraksha Diagnostic. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹313.10, shares in Suraksha Diagnostic were trading -3.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Suraksha Diagnostic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹313.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Suraksha Diagnostic's directors